The FDA recently approved our personalized medicine for two different indications: ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumors.
?? of 40 moments published
Tell us what you think about our company, products, or website.
Science is a way of thinking much more than it is a body of knowledge.